Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta

ClinicalTrials.gov ID: NCT00131118

Public ClinicalTrials.gov record NCT00131118. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 7, 2026, 5:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an extension study to examine the long-term safety and efficacy of zoledronic acid in patients who have completed the core CZOL446H2202 study.

Study identification

NCT ID
NCT00131118
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
127 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
1 Year to 17 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2004
Primary completion
Apr 30, 2007
Completion
Apr 30, 2007
Last update posted
May 31, 2017

2004 – 2007

United States locations

U.S. sites
10
U.S. states
9
U.S. cities
10
Facility City State ZIP Site status
UCLA Medical Center-Dept of Pediatric Nephrology Los Angeles California 90095
Alfred Dupont Hospital for Children Wilmington Delaware 19899
Intermountains Orthopedics Boise Idaho 83702
Children's Hospital Omaha Nebraska 68198
For information regarding facilities, please contact the Central Contact Multiple Locations New Jersey
Children's Hospital Medical Center Cincinnati Ohio 45229
Children's Hospital Columbus Ohio 43205
Oregon Health Sciences University Portland Oregon 97239
Vanderbilt University Medical Center Nashville Tennessee 37232
Texas Children's Hospital Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00131118, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 31, 2017 · Synced Sep 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00131118 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →